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Background: The mode of action of Lycium chinense Miller root extract in skin care has never been explored. In the
present study, Lycium chinense Miller root was extracted by the supercritical fluid CO2 extraction method.
Methods: In the present study, the components of the root extract were analyzed by HPLC. The effects of the
extract on tyrosinase activity and melanin content were determined spectrophotometrically; the expression of
melanogenesis-related proteins was determined by Western blotting; the possible signaling pathways involved in
the root extract-mediated depigmentation were also investigated using specific inhibitors.
Results: The results revealed that the SFE of Lycium chinense Miller root (2.37-7.11 mg/mL) effectively suppressed
intracellular tyrosinase activity and decreased the melanin content in B16F10 cells. The root extract also effectively
decreased intracellular reactive oxygen species (ROS) levels. Furthermore, the root extract decreased the expression
of melanocortin 1 receptor (MC1R), microphthalmia-associated transcription factor (MITF), tyrosinase and
tyrosinase-related protein-1 (TRP-1) and then inhibited melanogenesis in B16F10 cells. The root extract also
showed antioxidant capacities and depleted cellular ROS.
Conclusions: Our results indicate that the SFE of Lycium chinense Miller root inhibited melanogenesis in
B16F10 cells by down-regulation of both mitogen-activated protein kinases (MAPK) and protein kinase A
(PKA) signaling pathways or through its antioxidant properties.
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Melanin is secreted by melanocytes that are distributed
in the basal layer of the skin epidermis [1]. Melanin is
responsible for skin color and also plays a key role in
protecting the skin against ultraviolet (UV) sunlight
damage. Various dermatological disorders result from
the accumulation of an excessive level of epidermal mel-
anin. Hyperpigmented skin disorders include melasma,
age spots, freckles and sites of actinic damage [2]. The
inhibitors of melanogenesis have been increasingly applied
in skin care products for the treatment or prevention of* Correspondence: ctm@sunrise.hk.edu.tw
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unless otherwise stated.skin hyperpigmentation [3]. Tyrosinase (EC 1.14.18.1) is a
copper-containing enzyme that catalyzes the first two
steps of melanin synthesis. It first hydroxylates L-tyrosine
to L-3,4-dihydroxyphenylalanine (L-DOPA), and L-DOPA
is further oxidized to the corresponding o-dopaquinone
[4]. There are many factors that participate in the regulation
of melanin synthesis. For example, the microphthalmia-
associated transcription factor (MITF), tyrosinase-related
protein-1 (TRP-1) and tyrosinase-related protein-2 (TRP-
2) are known to regulate the production of melanin [5-7].
Moreover, the melanocortin 1 receptor (MC1R) also plays
an important role in melanocyte stimulating hormone
(MSH)-induced melanogenesis [8]. Furthermore, it is
reported that melanogenesis produces hydrogen perox-
ide (H2O2) and reactive oxygen species (ROS), which
lead to the generation of high-grade oxidative stress inLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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inhibitors of ROS generation have been reported to in-
hibit UV-induced melanogenesis [9]. Antioxidants such
as reduced glutathione (GSH) and ascorbic derivatives
have been applied to inhibit or delay hyperpigmentation
[10,11]. Hence, antioxidants and free radical scavengers
also play an important role in the regulation of melanin
synthesis. Recently, we also reported that certain plant
extracts [12], essential oils [13,14] and microbial metabo-
lites [15,16] exhibit dual antioxidant and anti-melanogenic
activities.
Lycium chinense Miller, also called boxthorn, is a plant
belonging to the family Solanaceae that is widely distrib-
uted in East Asia. The leaves and fruits of boxthorn have
been used as foods or medicine in the Orient. Boxthorn
leaves have been reported to exhibit tranquillizing,
thirst-quenching and anti-aging activity. In addition, the
leaves of Lycium chinense Miller are known to reduce
the risk of certain diseases such as arteriosclerosis, diabetes
and night blindness [17]. The fruits of Lycium chinense
Miller have been used traditionally for anti-aging [18] and
hepatoprotective purposes [19]. In addition, the fruits have
been reported to show antipyretic, hypoglycemic and
hypotensive activities in animal models [20]. Recently, it
was reported that zeaxanthin dipalmitate, a carotenoid
from L. chinense fruits, significantly reduced the prolifera-
tion of myofibroblast-like cells (MFBLCs) and collagen
synthesis in cultured hematopoietic stem cells (HSCs)
in vitro [21]. However, there is relatively little knowledge
regarding the modes of action of Lycium chinense Miller
root extract in skin care or dermatology.
The aim of current study was to investigate the anti-
melanogenic activity of the supercritical fluid extract of
Lycium chinense Miller root in murine B16F10 melanoma
cells. We also evaluated the potential action mechanisms
of the root extract in melanogenesis.
Methods
Chemicals and reagents
The chemical reagents were purchased from Sigma Chem-
ical Co. (St. Louis, MO, USA). The antibodies were obtained
from Santa Cruz Biotech (Santa Cruz, CA, USA) and the
ECL reagent from Millipore (MA, USA). Protein kinase
regulators, including3-isobutyl-1-methyl-xanthine (IBMX),
SB203580 (p38 MAPK-inhibitor), SP600125 (c-Jun N-
terminal kinase inhibitor; JNK inhibitor) and PD98059
(MEK 1/2-inhibitor), were obtained from Tocris (Ellisville,
Missouri, USA).
Preparation of Lycium chinense Miller root powder
The Lycium chinense Miller roots were harvested in June
2012 from a farm located at Guanyin Township, Taoyung
County, Taiwan. The roots of Lycium chinense Miller were
identified in the National Research Institute of ChineseMedicine (NRICM), Ministry of Health and Welfare,
Taiwan. Besides, there was a botanically identified vou-
cher specimen (NHP-00219) deposited in the institute.
The roots were washed completely, exposed to sunlight
and air-dried for one day. The roots were sliced into
pieces and exposed to sunlight for 7 more days and then
dried at 80°C for 2 h in an oven. The dehydrated root
slices were pulverized to a fine powder (#20 mesh) with
a centrifugal mill (Retsch Ultra Centrifugal Mill and
Sieving Machine, Type ZM1, Haan, Germany). The pow-
der was collected in a sealed glass bottle and stored at
25°C until use.
Supercritical fluid CO2 extraction (SFE) of Lycium chinense
Miller root
The pulverized, desiccated Lycium chinense Miller root
(83 g) was placed in the extraction vessel (200 ml) of a
supercritical fluid CO2 extraction (SFE) apparatus (SFE-
400S-2000, Metal Industries Research & Development
Centre; MIRDC; Kaohsiung, Taiwan). Extraction was
performed with a 10% co-solvent of ethanol in supercrit-
ical fluid CO2 (flow rate, 5.0 ml/min) at 5,000 psi
(=350 bar) at 50°C for 2 h. The extracts were evaporated
to dryness in a rotary evaporator at 40°C under reduced
pressure. The concentrated SFEs were weighed and
stored at −20°C. In the following experiments, the SFEs
were re-dissolved in dimethyl sulfoxide (DMSO) as
indicated.
HPLC analysis of Lycium chinense Miller root SFE
The Lycium chinense Miller root SFE sample was mixed
with an internal standard solution (66 mg of naringin
was diluted to 12 ml with 70% methanol) in a ratio of
99:1. Then, samples were spiked with various concentra-
tions of stock solutions and analyzed. A stock solution
was prepared by dissolving two marker substances
(rutin, 1 mg and liquiritigenin, 2 mg in 1 ml of 70%
methanol) and stored in a refrigerator. Before adding the
internal standard solution, the stock solution was then
diluted with 70% methanol into a series of standard solu-
tions (rutin: 4.95, 6.6, 9.9, 19.8 and 39.6 μg/ml; liquiriti-
genin: 7.07, 8.25, 9.9, 12.375 and 24.75 μg/ml). Twenty
microliters of these solutions was injected, and the samples
were analyzed twice by the HPLC method; standard curves
were plotted according to the peak areas versus concentra-
tions. Recovery was determined by comparing of the
amount of marker substances added with the marker sub-
stances found. The limits of detection were based on a
signal-to-noise (S/N) ratio of 3:1 as a minimum.
HPLC was performed on an Agilent 1220 series system.
Satisfactory separation of the market substances, obtained
with a reversed-phase column (Cosmosil 5 C18-AR II,
5 μm, 25 cm× 4.6 mm I.D., Nacalai Tesque, Kyoto, Japan)
at 25°C, was eluted at a flow rate of 0.8 ml/min with a
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B = CH3CN: CH3OH = 2: 1 (v/v)] as follows: 5 min,
0% B; 10 min, 15% B; 20 min, 20% B; 50 min, 26% B;
70 min, 30% B.
Cell culture and cell viability assay
B16F10 cells (ATCC CRL-6475, BCRC60031) were ob-
tained from the Bioresource Collection and Research
Center (BCRC), Taiwan. The cells were maintained in
DMEM (Hyclone, Logan, UT) supplemented with 10%
fetal bovine serum and 1% antibiotics at 37°C, 5% CO2
in a humidified incubator.
The cell viability assay was performed using 3-(4,
5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) [22]. The cells were exposed to various concentra-
tions of Lycium chinense Miller root SFE for 24 h, and the
MTT solution was then added to the wells. The insoluble
derivative of MTT produced by intracellular dehydrogen-
ase was solubilized with ethanol-DMSO (1:1 mixture solu-
tion). The absorbance of the wells at 570 nm was read
using a microplate reader.
Assay of mushroom tyrosinase activity
Enzyme inhibition experiments were conducted as previ-
ously described [23]. Briefly, 10 μL of an aqueous solu-
tion of mushroom tyrosinase (200 units) was added to a
96-well microplate to produce a 200-μL mixture con-
taining 5 mM L-DOPA, which was dissolved in 50 mM
phosphate buffered saline (PBS) (pH 6.8), Lycium chi-
nense Miller root SFE (5.93, 11.85 and 23.7 mg/mL) or
kojic acid (200 μM). The assay mixture was incubated at
37°C for 30 min, and the absorbance of dopachrome was
measured at 490 nm.
Measurement of melanin content
The intracellular melanin content was measured as de-
scribed by Tsuboi et al. [24]. The cells were treated with
α-MSH (100 nM) for 24 h, and the melanin content was
then determined after treatment with either Lycium chi-
nense Miller root SFE (2.37, 4.74 and 7.11 mg/mL) or
arbutin (2 mM) for an additional 24 h. After treatment,
the cell pellets containing a known number of cells were
solubilized in 1 N NaOH at 60°C for 60 min. The mel-
anin content was assayed at 405 nm.
Assay of intracellular tyrosinase activity
The cellular tyrosinase activity was determined as described
previously [25]. The cells were treated with α-MSH
(100 nM) for 24 h and then with Lycium chinense
Miller root SFE (2.37, 4.74 and 7.11 mg/mL) or arbutin
(2 mM) for 24 h. After the treatments, the cell extracts
(100 μL) were mixed with freshly prepared L-DOPA
solution (0.1% in PBS) and incubated at 37°C, and the
absorbance at 490 nm was measured.Western blotting assay
The cells were treated with Lycium chinense Miller root
SFE (2.37, 4.74 and 7.11 mg/mL) or kojic acid (200 μM)
and lysed in proteinase inhibitor containing PBS at
4°C for 20 min. Proteins (50 μg) were resolved by SDS-
polyacrylamide gel electrophoresis and electrophoretically
transferred to a polyvinylidene fluoride (PVDF) filter. The
filter was blocked in 5% fat-free milk in PBST buffer (PBS
with 0.05% Tween-20) for 1 h. After a brief wash, the filter
was incubated overnight at 4°C with several antibodies;
these antibodies included anti- MITF (1:1000), anti-TRP1
(1:6000), anti-TRP2 (1:1000), anti- MC1R (1:500), anti-
GAPDH (1:1500), anti-tyrosinase (1:2000), anti-p-p38
(1:500), anti-p38 (1:500), anti-p-JNK (1:500), anti-JNK
(1:500), anti-p-ERK (1:500) and anti-ERK (1:500). Follow-
ing incubation, the filter was extensively washed in PBST
buffer. Subsequent incubation with goat anti-mouse anti-
body (1:10000) conjugated with horseradish peroxidase
was conducted at room temperature for 2 h. The blot was
visualized using an ECL reagent. The relative amounts of
expressed proteins compared to total GAPDH were ana-
lyzed using Multi Gauge 3.0 software (Fuji, Tokyo).
Protein kinase regulators assay
The cells were treated with α-MSH (100 nM) for 24 h
followed by a 1-h addition of 10 μM of different protein
kinase regulators, including PD98059, SB203580, SP600125
and IBMX. After these treatments, Lycium chinense Miller
root SFE (2.37, 4.74 and 7.11 mg/mL) and 10 μM of the
above-mentioned kinase regulators were added to the cells
and incubated for an additional 23 h. The melanin con-
tents were assayed as described above.
ABTS+ scavenging capacity assay
ABTS decolorization assays were carried out as previously
described [26], which involved the generation of ABTS+
chromophore by the oxidation of ABTS with potassium
persulfate. The ABTS radical cation (ABTS+) was pro-
duced by reacting 7 mM stock solution of ABTS with
2.45 mM potassium persulfate and allowing the mixture
to stand in the dark for at least 6 h at room temperature
before use. The absorbance at 734 nm was measured
10 min after mixing different concentrations of the Lycium
chinense Miller root SFE (final concentration 2.37, 4.74,
7.11 mg/mL) with 1 ml of ABTS+ solution. The ABTS+
scavenging capacity of the extract was compared with that
of vitamin C (50 μM) and BHA (0.1 mg/mL).
Determination of total phenolic content
The amount of total phenolics in the Lycium chinense
Miller root SFE was determined with the Folin-Ciocalteu
reagent [27]. First, a standard curve was plotted using
gallic acid as a positive standard. Different concentrations
of the root extracts were prepared in 80% methanol. One
Figure 1 HPLC chromatogram of Lycium chinenseMiller root SFE.
Figure 2 Effect of Lycium chinense Miller root SFE on the
proliferation of B16F10 cells. Cell viability was measured by trypan
blue dye exclusion method after 24 h of incubation. Data are
expressed as a percentage of the number of viable cells observed
with the control, and in each column, mean values ± SD from two
or three independent experiments performed in triplicate is
presented. *indicates p < 0.05 compared to control by ANOVA test.
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(1/10 dilution) of the Folin-Ciocalteu reagent and 1000 μL
of distilled water. The solutions were mixed and incubated
at room temperature for 1 min. After 1 min, 1500 μL of
20% sodium carbonate solution was added. The final mix-
ture was shaken and then incubated for 2 h in the dark at
room temperature. The absorbances of samples and gallic
acid (2.5 and 5 μg/ml) were measured at 760 nm.
Determination of cellular ROS level
The cells were treated with Lycium chinense Miller root
SFE (2.37, 4.74 and 7.11 mg/mL) and cultured in 24-well
plates for 24 h. The cells were then incubated with
24 mM H2O2 at 37°C for 30 min. After incubation, 2′,7′-
dichlorofluorescein diacetate (DCFH-DA) was added to
the wells and cultured for 30 min. The fluorescence inten-
sities of DCF were measured at an excitation wavelength
of 504 nm and an emission wavelength of 524 nm [28]
using a Fluoroskan Ascent fluorescent reader (Thermo
Scientific, Vantaa, Finland). The data were analyzed using
Ascent software (Thermo Scientific, Vantaa, Finland).
Statistical analysis
Statistical analysis of the experimental data points was
performed by the ANOVA test, which was used to com-
pare measured data using the SPSS 12.0 statistical software
program (SPSS INC. Chicago, USA). Differences were con-
sidered statistically significant at p < 0.05.
Results
HPLC calibration curves were prepared by plotting the
peak-area ratios (using naringin as an internal standard)
against the corresponding concentrations. For rutin,
y = 129.15x - 0.1755 (R2 = 0.9921); for liquiritigenin,
y = 66.785x + 0.0688 (R2 = 0.9906). The detection limits
(S/N = 3) for the components were 0.155 (rutin), and
0.387 (liquiritigenin) μg/ml. Suitable amounts of marker
substances (rutin, 9.94 μg/mL, and liquiritigenin, 8.29 μg/mL)
were added to a sample containing a known content,
and the mixture was analyzed by the proposed method.
The recoveries of the components were 100.41 (rutin)
and 100.43% (liquiritigenin). By substituting the peak-
area ratios of the individual peaks for y in the equations,
the contents of the individual components in sample ex-
tracts were determined by HPLC. The average amount
of rutin in Lycium chinense Miller root SFE was 23.04 ±
0.172 μg/mL (Figure 1).
The MTT assay was used to assess the effect of Lycium
chinense Miller root SFE on the viability of B16F10 cells.
The cells were treated with various concentrations of the
root SFE (2.37, 4.74 and 7.11 mg/mL) for 24 h, and then
the MTT assay was performed. The results are expressed
as percent viability relative to the viability of the control.
After treatment, Lycium chinense Miller root SFE showedno cytotoxic effect on B16F10 cell viability (Figure 2). The
results shown in Figure 3A indicate that the remaining
mushroom tyrosinase activity was 83.15 ± 1.25%, 74.84 ±
2.62% and 69.42 ± 2.63% that of the control for the 5.93,
11.85 and 23.7 mg/mL of Lycium chinense Miller root SFE
treatments, respectively. In addition, the tyrosinase activity
was also inhibited by kojic acid (200 μM), and the
remaining enzyme activity was 58.14 ± 1.05% that of the
control (Figure 3A). Thus, Lycium chinense Miller root
SFE could be an inhibitor of mushroom tyrosinase, and
the IC50 was 49.32 mg/mL.
The results indicate that lower concentrations of the
Lycium chinense Miller root SFE significantly decreased
the melanin content in B16F10 melanoma cells. After
treatment, the melanin contents in the cells were 91.21 ±
Figure 3 The inhibitory effects of Lycium chinense Miller root SFE on melanogenesis. (A). The effects of Lycium chinense Miller root SFE on
mushroom tyrosinase activity. (B). The effects of Lycium chinense Miller root SFE on melanin content in B16F10 cells. (C). The effects of Lycium
chinense Miller root SFE on tyrosinase activity in B16F10 cells. The results are presented as percentages of the control values, and the data are
presented as the mean ± S.D. of three separate experiments. The values are significantly different compared with the control. *p < 0.05; ***p < 0.001.
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and 7.11 mg/mL of Lycium chinense Miller root SFE treat-
ments, respectively. The IC50 was 11.01 mg/mL. For the
positive standard arbutin (2 mM), the remaining intracel-
lular melanin content was 74.73 ± 1.51% that of the con-
trol (Figure 3B). The remaining intracellular tyrosinase
activities were 91.69 ± 4.59%, 74.12 ± 2.2% and 62.34 ±
1.8% for the 2.37, 4.74 and 7.11 mg/mL of Lycium
chinense Miller root SFE treatments, respectively. The
IC50 of the root SFE was 8.95 mg/mL. The remaining
intracellular tyrosinase activity was 67.07 ± 1.6% that
of the control after the cells were treated with arbutin
(2 mM) (Figure 3C). The results indicate that a higher
concentration of Lycium chinense Miller root SFEexhibited a potent inhibitory effect on α-MSH-induced
tyrosinase activity in B16F10 cells.
The expression levels of melanogenesis-related pro-
teins were examined using Western blots (Figure 4A).
The results indicate that the 2.37-7.11 mg/mL of Lycium
chinense Miller root SFE treatment led to a reduced level
of MC1R, TRP-1 and TRP-2. The inhibitory effects of
the root SFE on MITF and tyrosinase expression were
apparent at the concentration of 7.11 mg/mL. The fold
changes of protein expression levels for MCIR were
0.82, 0.82 and 0.45; 0.68, 0.51 and 0.38 for TRP-1; and
0.67, 0.61 and 0.60 for TRP-2 for the 2.37, 4.74 and
7.11 mg/mL of Lycium chinense Miller root SFE treat-





Figure 4 The effects of Lycium chinense Miller root SFE on melanogenesis-related protein expression and signaling pathways. (A), (C).
Western blotting of cellular proteins in B16F10 cells. (B), (D). The relative amounts of MITF, TRP-1, tyrosinase, TRP-2 and MC1R or phosphorylated
proteins (p-JNK, p-ERK and p-p38) compared to the total GAPDH were calculated and analyzed using Multi Gauge 3.0 software, and the values
represent the mean of triplicate experiments ± standard deviations. *p < 0.05.
Figure 5 The effects of Lycium chinense Miller root SFE on
melanin content in PD98059, SB 203580-, SP600125- and IBMX-
treated B16F10 cells. The results are presented as percentages of
the control values, and the data are presented as the mean ± S.D. of
three separate experiments. The values are significantly different
compared with the control. *p < 0.05.
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ment with 7.11 mg/mL of the root SFE (Figure 4B).
The JNK signaling pathway is involved in regulating
melanogenesis. The results shown in Figure 4C reveal
that Lycium chinense Miller root SFE decreased the ex-
pression of p-JNK; the fold changes of p-JNK in B16F10
cells were 0.83, 0.87 and 0.74 for the 2.37, 4.74 and
7.11 mg/mL of Lycium chinense Miller root SFE treat-
ments, respectively. As shown in Figure 4C, various con-
centrations of Lycium chinense Miller root SFE decreased
the expression of p-p38; the fold changes of p-p38 in
B16F10 cells were 0.95, 0.98 and 0.93 for the 2.37, 4.74
and 7.11 mg/mL of Lycium chinense Miller root SFE treat-
ments, respectively. The ERK signaling pathway is also re-
ported to be involved in regulating melanogenesis. The
results shown in Figure 4C reveal that Lycium chinense
Miller root SFE decreased the expression of p-ERK; the
fold changes of p-ERK in B16F10 cells were 1.01, 0.46 and
0.37 for the 2.37, 4.74 and 7.11 mg/mL of Lycium chinense
Miller root SFE treatments, respectively. Furthermore, the
addition of the root SFE to SP600125-treated B16F10 cells
significantly decreased the cellular melanin content, which
indicates that the JNK-mediated signaling pathway was
affected by Lycium chinense Miller root SFE (Figure 5).
To further investigate the role of p38 MAPK signaling
on the Lycium chinense Miller root SFE-induced anti-
melanogenic effect, we employed a specific inhibitor ofp38, SB203580, which blocks p38 MAPK signaling. The
results shown in Figure 5 reveal that the specific inhibitor
of p38 MAPK, SB203580, attenuated α-MSH-stimulated
melanin synthesis. These results suggest that Lycium
chinense Miller root SFE inhibited melanin synthesis by
down-regulating p38 MAPK signaling and subsequently
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cells. The addition of Lycium chinense Miller root SFE in
PD98059-treated B16F10 cells significantly decreased the
cellular melanin content. The results indicate that the
ERK-mediated signaling pathway involved in melanin pro-
duction was affected by Lycium chinense Miller root SFE
treatment (Figure 5). The PKA signaling pathway is asso-
ciated with regulating melanogenesis. The application of
Lycium chinense Miller root SFE in IBMX-treated B16F10
cells significantly decreased the cellular melanin con-
tent. The results indicate that cAMP-mediated PKA sig-
naling was affected by Lycium chinense Miller root SFE
(Figure 5).
The ABTS+ assay was employed to measure the anti-
oxidant activity of the Lycium chinense Miller root SFE.
Different concentrations of the extract (final concentra-
tion 2.37, 4.74, 7.11 mg/mL), Vitamin C (50 μM) and
BHA (0.1 mg/mL) were incubated with ABTS+ solution.
The ABTS+ scavenging capacities of the extract were
20.12 ± 2.81%, 34.89 ± 2.13% and 51.53 ± 2.65% the activity
of the control for extract concentrations of 2.37, 4.74 and
7.11 mg/mL, respectively. Moreover, the ABTS+ scaven-
ging capacities of Vitamin C and BHA were 71.72 ± 2.07%
and 91.11 ± 0.24%, respectively. The results indicate that
the Lycium chinense Miller root SFE scavenges ABTS+ free
radical significantly in a dose-dependent manner. How-
ever, the extract showed a lower ABTS+ radical scavenging
capacity than Vitamin C or BHA does (Figure 6A).
To determine the total phenolic contents of the Lycium
chinense Miller root SFE (2.37, 4.74 and 7.11 mg/mL),
gallic acid (2.5 and 5 μg/ml) was used as a positive stand-
ard. The results in Figure 6B showed that the total phen-
olic contents in 2.37, 4.74 and 7.11 mg/mL of the Lycium
chinense Miller root SFE was 56.43 ± 1.66%, 70.43 ± 1.15%,
78.15 ± 0.49%, respectively. The phenolic content of
7.11 mg/mL of the extract was similar to that of 2.5 μg/ml
of gallic acid (74.2 ± 0.23%).
To confirm the antioxidant capacity of the Lycium
chinense Miller root SFE in a cellular environment, intracel-
lular ROS levels were evaluated. The concentration of H2O2
employed was 24 mM. After treatment, the remaining
intracellular ROS induced by H2O2 was 70.62 ± 2.67% for
7.11 mg/mL of the extract and 53.45 ± 1.08% for Trolox
(2 mM) (Figure 6C).
Discussion
The HPLC analysis results shown in Figure 1 reveal that
rutin may be the major component in the Lycium chinense
Miller root SFE. Interestingly, it was reported that the ad-
ministration of rutin inhibited melanin formation and the
decreased melanin content of B16 melanotic melanoma in
C57BL/6 mice [29], which supports our proposal that the
rutin in the root SFE may play an important role in the in-
hibition of melanogenesis in melanoma cells.The MTT assay is a colorimetric assay used to meas-
ure cell viability. It can also be used to determine the
cytotoxicity of potential medicinal agents and toxic ma-
terials because those agents enhance or inhibit cell via-
bility. The results shown in Figure 2 indicate that even
higher concentrations of the Lycium chinense Miller root
SFE (7.11 mg/mL) also showed no cytotoxic effect on
B16F10 melanoma cell viability. The Lycium chinense
Mill root SFE sample (11.85 mg/mL and 23.7 mg/mL)
resulted in minor cytotoxicity, while the lower concen-
tration did not substantially induce a cell morphology
change 24 h post-irradiation (data not shown). Thus, we
applied 2.37-7.11 mg/ml for the following experiments.
Mushroom tyrosinase is widely used as the target enzyme
in screening potential inhibitors of melanogenesis. It was
first observed that the dosage range (2.37-7.11 mg/mL) of
the Lycium chinense Miller root SFE could not inhibit the
activity of mushroom tyrosinase (data not shown). The
Lycium chinense Mill root SFE (5.93-23.7 mg/mL) had in-
hibitory effect on tyrosinase activity using L-DOPA as a
substrate. The IC50 of Lycium chinense Mill root SFE was
found to be 49.32 mg/mL. Kojic acid had strong inhibitory
effect on tyrosinase (58.14 ± 1.05% at concentrations of
200 μM) (Figure 3A). Tyrosinase is well known to play an
essential role in the first two steps of the melanin synthesis
pathway. To elucidate the true inhibitory effect of Lycium
chinense Miller root SFE on melanin production, the
B16F10 melanin content and intracellular tyrosinase activ-
ity were determined. The results shown in Figure 3B indi-
cate that the Lycium chinense Miller root SFE presents a
stronger inhibitory effect on melanin formation than arbu-
tin does. The data provide evidence that Lycium chinense
Miller root SFE truly blocks melanogenesis in melanoma
cells. The results shown in Figure 3C are in accord with
the results indicated in Figure 3B, which suggests that the
Lycium chinense Miller root SFE inhibited intracellular
tyrosinase activity and then decreased the melanin con-
tent. In those experiments, α-MSH was used as a cAMP
inducer to stimulate melanin synthesis. It is reported that
α-MSH can bind melanocortin 1 receptor (MC1R) and
activate adenylate cyclase, which in turn catalyzes ATP
to cAMP and increases intracellular cAMP levels [30].
The results reveal that the Lycium chinense Miller root
SFE inhibited melanogenesis induced by α-MSH-mediated
intracellular cAMP up-regulation.
It has been reported that binding of the human MC1R
by its ligands can activate the cAMP signaling pathway
and regulate pigmentation of human melanocytes [31].
Melanin biosynthesis in mammalian cells is directly reg-
ulated by three major enzymes, tyrosinase, TRP-1 and
TRP-2 [32]. Furthermore, MITF is well known to be the
most important regulator of melanocyte differentiation
and pigmentation and is the major transcriptional regu-
lator of the tyrosinase, TRP-1 and TRP-2 genes [33]. The
Figure 6 The antioxidant characteristics of the effect of Lycium chinense Miller root SFE. (A). ABTS+ radical scavenging activity assay. The
root extract (final concentration 2.37, 4.74, 7.11 mg/mL), vitamin C (50 μM) and BHA (0.1 mg/mL) were incubated with ABTS+ solution.
(B). Determination of total phenolic content. Different concentrations of the Lycium chinense Miller root SFE (2.37, 4.74, 7.11 mg/mL) and gallic
acid (2.5 and 5 μg/ml) were used in the assay. (C). Lycium chinense Miller root SFE decreased the cellular ROS level. The B16F10 cells were treated
with various concentrations of the root extract (2.37, 4.74, 7.11 mg/mL) or Trolox (2 mM) for 24 h, and then the ROS content was measured by
the DCF-DA assay. The results are expressed as percentages of the control values. The data are presented as the mean ± S.D. ***p < 0.001.
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the Lycium chinense Miller root SFE decreased the protein
expression levels of those proteins, then inhibited tyrosin-
ase activity and finally decreased the melanin content in
the B16F10 cells. The results shown in Figure 4 indicate
that Lycium chinense Miller root SFE decreased MC1R ex-
pression and further suggests that Lycium chinense Miller
root SFE inhibited melanogenesis induced via α-MSH-
mediated intracellular cAMP up-regulation. Moreover, the
results shown in Figure 5 further confirm that Lycium chi-
nense Miller root SFE inhibited cAMP-mediated PKA
signaling.
It has been reported that MAPKs modulate melanin
synthesis [34-36]. The MAPK family is composed of three
types of protein kinases, extracellular responsive kinase
(ERK), c-Jun N-terminal kinase (JNK) and p38 MAPK.
The p38 MAPK can activate the cAMP response element-
binding protein (CREB), and CREB activates MITFexpression, which positively contributes to melanin produc-
tion [37]. The results in Figure 4C provide evidence that
Lycium chinense Miller root SFE could inactivate CREB,
JNK and p38, in turn inhibiting MITF expression
(Figure 4A). Furthermore, Protein kinase A (PKA) signal-
ing is also reported to be involved in melanin production
[38]. The α-MSH-mediated elevation of cellular cAMP
levels could activate PKA. In turn, activated PKA can acti-
vate CREB, leading to the activation of MITF transcrip-
tional activity and resulting in the expressions of
melanogenesis-related proteins. Our results shown in
Figure 5 also suggest that Lycium chinense Miller root SFE
inhibits melanin synthesis by blocking the PKA pathway.
The ABTS+ free radical has been widely applied to esti-
mate the free radical scavenging activity of antioxidants.
Antioxidants can either transfer electrons or hydrogen
atoms to ABTS+, thus neutralizing the species’ free radical
character. In the present study, the Lycium chinense Miller
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ities compared to the activity of Vitamin C or BHA
(Figure 6A).
When assaying the total phenolic content of the Lycium
chinense Miller root SFE, it was interesting to find that a
higher concentration of the root extract (7.11 mg/mL) has
a highertotal phenolic content. This is probably due to
most bioactive compounds such as polyphenols including
tannins and flavonoid in the extracts. Polyphenols are one
of the major plant compounds with antioxidant activity.
The antioxidant activity of phenolic compounds is re-
ported to be mainly due to their redox properties, which
can play an important role in adsorbing and neutralizing
free radicals, quenching singlet and triplet oxygen or de-
composing peroxides [27].
To confirm the antioxidant capacity of Lycium chinense
Miller root SFE in a cellular environment, intracellular
ROS levels were evaluated. The principle of the assay is
based on the fact that DCFH-DA diffuses through the cell
membrane and is enzymatically hydrolyzed by esterase to
DCFH, which reacts with ROS (such as H2O2) to yield
DCF. Rapid increases in DCF indicate the oxidation of
DCFH by intracellular radicals. The results reveal that the
flower extract depleted intracellular ROS in a dose-
dependent manner. The skin is exposed to UV and envir-
onmental oxidizing pollutants and is a preferred target of
oxidative stress. It is reported that ultraviolet irradiation
induces the formation of reactive oxygen species (ROS) in
cutaneous tissue, provoking toxic changes such as lipid
peroxidation and enzyme inactivation [39]. It is reported
that chronic exposure to solar UV radiation plays a role in
the initiation of several skin hyperpigmentation disorders
[40]. Therefore, there is an increasing need for new and
effective agents that exhibit photoprotection and skin
anti-hyperpigmentation activities to prevent abnormal
skin pigmentation disorders. To date, there is no report
about the effect of Lycium chinense Miller root SFE on
melanin production. This is the first study to evidence the
potential inhibitory effect of Lycium chinense Miller root
SFE on melanogenesis in B16F10 melanoma cells. In
addition, the root extract also shows antioxidant capaci-
ties, which fits the trend of skin anti-hyperpigmentation
agents that show dual functions in anitimelanogenesis and
antioxidation. Recently, several plants such as Paeonia suf-
fruticosa [41] and chestnut flower extract [42] have also
been reported to show antioxidant and antimelanogenic
properties similar to those of Lycium chinense Miller root
SFE. The results suggest that Lycium chinense Miller root
SFE decreased melanin production due to its depletion of
cellular ROS.
Our results indicate that Lycium chinense Miller root
SFE inhibited melanogenesis in B16F10 cells by down-
regulation of both mitogen-activated protein kinases
(MAPK) and protein kinase A (PKA) signaling pathwaysor through its antioxidant properties. Hence, Lycium
chinense Miller root SFE could be used as an effective
skin anti-hyperpigmentation agent.
Conclusions
This is the first report on the inhibitory effect of Lycium
chinense Miller root SFE on melanin synthesis. We also
analyzed the antioxidant capacities of the root SFE of
Lycium chinense Miller. The present study concluded
that Lycium chinense Miller root SFE inhibits melanin
synthesis in B16F10 melanoma cells and showed antioxi-
dant potential. The present results indicate that the
Lycium chinense Miller root SFE inhibited melanin synthe-
sis in B16F10 melanoma cells by down-regulation of both
mitogen-activated protein kinases (MAPK) and protein
kinase A (PKA) signaling pathways or through its intra-
cellular antioxidant properties. Hence, the SFE of Lycium
chinense Miller root could be applied as a type of der-
matological anti-hyperpigmentation agent in skin care
products.
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